- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-1827
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cannabinoids as anticancer drugs: current status of preclinical research ; volume:127 ; number:1 ; day:11 ; month:3 ; year:2022 ; pages:1-13 ; date:7.2022
British journal of cancer ; 127, Heft 1 (11.3.2022), 1-13, 7.2022
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41416-022-01727-4
- URN
-
urn:nbn:de:101:1-2022091501481883764549
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:19 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hinz, Burkhard
- Ramer, Robert Georg
- SpringerLink (Online service)
Other Objects (12)
Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development
Cannabinoids
Current advances of anticancer drugs based on solubilization technology
New anticancer drugs
Metabolomics in Preclinical Drug Safety Assessment : Current Status and Future Trends
Cannabinoids as therapeutics
Pharmacogenetics of Cannabinoids
Cannabinoids as Cocrystals
Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation
Empagliflozin: a potential anticancer drug
CDK7 inhibitors as anticancer drugs
In silico investigation of cannabinoids from Cannabis sativa leaves as a potential anticancer drug to inhibit MAPK-ERK signaling pathway and EMT induction
Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development
Cannabinoids
Current advances of anticancer drugs based on solubilization technology
New anticancer drugs
Metabolomics in Preclinical Drug Safety Assessment : Current Status and Future Trends
Cannabinoids as therapeutics
Pharmacogenetics of Cannabinoids
Cannabinoids as Cocrystals
Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation
Empagliflozin: a potential anticancer drug
CDK7 inhibitors as anticancer drugs
In silico investigation of cannabinoids from Cannabis sativa leaves as a potential anticancer drug to inhibit MAPK-ERK signaling pathway and EMT induction
Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development
Cannabinoids
Current advances of anticancer drugs based on solubilization technology
New anticancer drugs
Metabolomics in Preclinical Drug Safety Assessment : Current Status and Future Trends
Cannabinoids as therapeutics
Pharmacogenetics of Cannabinoids
Cannabinoids as Cocrystals
Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation
Empagliflozin: a potential anticancer drug
CDK7 inhibitors as anticancer drugs